Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem-cell transplant preparative regimens.

J E Sanders1

  • 1Department of Pediatrics, University of Washington, Seattle 98109, USA. jsanders@fhcrc.org

Pediatric Transplantation
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing an adjustable prosthetic socket in a simulated military environment.

Journal of rehabilitation and assistive technologies engineering·2025
Same author

Single- and multiple-dose pharmacokinetics of sotalol hydrochloride in healthy cats.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2023
Same author

National hospital readiness for COVID-19 in Lesotho: evidence for oxygen ecosystem strengthening.

Public health action·2021
Same author

OCT-based microangiography for reactive hyperaemia assessment within residual limb skin of people with lower limb loss.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2017
Same author

Development of tuberculosis infection control guidelines in a pediatric HIV clinic in sub-Saharan Africa.

Public health action·2015
Same author

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.

Bone marrow transplantation·2013
Same journal

Single-Center Experience in Pediatric Lung Transplantation: Clinical Characteristics, Survival, and Post-Transplant Morbidity.

Pediatric transplantation·2026
Same journal

The Missing Link Between HLA Mismatch and Graft Failure: The Role of Donor-Specific Antibodies.

Pediatric transplantation·2026
Same journal

Truth or Consequences Revisited: Policymaking in Modern Organ Transplant.

Pediatric transplantation·2026
Same journal

First Single-Center Experience of Minimally Invasive Pediatric Living Donor Liver Transplantation in China.

Pediatric transplantation·2026
Same journal

Liver Retransplantation in Pediatric Recipients: A 20-Year Single-Center Experience With 25 Cases.

Pediatric transplantation·2026
Same journal

The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients.

Pediatric transplantation·2026
See all related articles

Developing new hematopoietic stem-cell transplantation (HSCT) regimens is crucial due to high recurrence rates in cancer patients. Future advancements will likely involve incremental improvements and novel approaches to minimize toxicity and maximize efficacy.

Area of Science:

  • Oncology
  • Hematology
  • Transplantation Medicine

Background:

  • Hematopoietic stem-cell transplantation (HSCT) is a critical treatment for malignancies.
  • High probabilities of disease recurrence post-HSCT necessitate improved preparative regimens.

Purpose of the Study:

  • To highlight the challenges and future directions in developing more effective HSCT regimens.
  • To identify strategies for reducing mortality and morbidity without compromising efficacy.

Main Methods:

  • Predictive analysis based on current data trends for HSCT regimen development.
  • Discussion of the need for large-scale controlled trials and cooperative group studies.
  • Exploration of novel therapeutic strategies, including tissue-protective agents and targeted therapies.

Related Experiment Videos

Main Results:

  • Predicts continued difficulty in identifying significantly more effective HSCT regimens.
  • Suggests that incremental improvements will be small and require large patient cohorts for validation.
  • Identifies promising avenues for future research and development.

Conclusions:

  • Further development of HSCT regimens is essential for managing malignancies.
  • Novel approaches like targeted radiolabeled antibodies and mixed chimerism hold promise.
  • Future HSCT regimen development requires innovation to balance efficacy with reduced toxicity.